Neuronal and BBB damage induced by sera from patients with secondary progressive multiple sclerosis. - Int J Mol Med. 2009 Dec;24(6):743-7. in PubMed

Type 1 diabetes mellitus and multiple sclerosis: common etiological features. - In this Review, we highlight the latest epidemiological and genetic findings, which have identified many features common to both disorders. - Nat Rev Endocrinal. 2009 Nov 3. [Epub ahead of print] in PubMed

Effect of neutralizing antibodies on biomarker responses to interferon beta: the INSIGHT study. - These data provide evidence that high titers of neutralizing antibodies abolish the in vivo response to interferon beta. - Neurology. 2009 Nov 3;73(18):1493-500. in PubMed

Effect of anti-IFN{beta} antibodies on MRI lesions of MS patients in the BECOME study. - High levels of anti-interferon beta (IFNbeta) antibodies, which result in diminished bioactivity, are correlated with reduced therapeutic efficacy of IFNbeta. -Neurology. 2009 Nov 3;73(18):1485-92. in PubMed

Resistance training improves muscle strength and functional capacity in multiple sclerosis. - Level of evidence: The present study provides level III evidence supporting the hypothesis that lower extremity progressive resistance training can improve muscle strength and functional capacity in patients with multiple sclerosis. - Neurology. 2009 Nov 3;73(18):1478-84. in PubMed

Time course transcriptomics of IFNB1b drug therapy in multiple sclerosis. - Autoimmunity. 2009 Nov 3. [Epub ahead of print] in PubMed

Progressive changes in the retinal nerve fiber layer in patients with multiple sclerosis. - Axonal loss in the optic nerve of patients with MS is greater than that expected in healthy subjects, regardless of the presence of a previous optic neuritis. - Eur J Opthalmol. 2009 Sep 30. [Epub ahead of print] in PubMed